Naughty or Nice ?
Biotech price action’s disconnecting from the rest of the market.
Around the last Fed meeting, biotech separated from the major indices, heading the opposite direction, i.e., sideways to higher.
We’ll see that as we get into the snapshots of the hourly charts (below), but first several clues on why biotech (so far) isn’t going along.
The Next Plan Rolls Out
First up is this, just out on ZeroHedge.
It appears the next push is on … and the target is the kids. Another wave of ‘protection’ is certain to boost profits.
Note: Those commenting on ZH have been ‘awake’ from the start; an invaluable resource.
Next up is this, just out on BrandNewTube; another clear thinker that helps ‘tie it all together’.
Is this the explanation for biotech’s current behavior?
Strictly speaking and from a Wyckoff perspective, we won’t know the real reason for a move until it’s nearing the end.
What we can see, is that character of price action has changed (again).
With that, we’ll look at the 3X, leveraged inverse funds of two indices, Russell 2000 (TZA) and SPBIO (LABD).
TZA & LABD, Hourly
The disconnect has been a recent observation.
We’ll drill right down to the hourly and put the charts one on top of the other.
We can see that while inverse TZA, is now back up to the pre-squeeze high, inverse LABD, is far below that level.
That’s not to say things can’t change quickly.
For now, however, there may be something else going on that’s keeping the sector buoyant and suppressing the LABD, inverse fund.
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279
Pingback: Claus & Effect, The Next Wave « The Danger Point®